Diluted EPS came in at $-0.14.
Trailing eight quarters through Q3 2024
Common questions about ProKidney Corp.'s Q3 2024 earnings report.
ProKidney Corp. (PROK) reported Q3 2024 earnings on November 12, 2024 before market open.
ProKidney Corp. reported diluted EPS of $-0.14 for Q3 2024.
EPS beat the consensus estimate of $-0.14 by $0.00.
You can read the 10-Q periodic report (0000950170-24-125312) directly on SEC EDGAR. The filing index links above go to sec.gov.